These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1899072

  • 1. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
    Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G.
    Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
    [Abstract] [Full Text] [Related]

  • 2. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A, Kramer MD, Schirrmacher V, Brunner G.
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW, Barnathan ES, Mazar A, Maheshwari S, Ellis S, Cortez SL, Baricos WH, Kleinman HK.
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
    Pelayo BA, Fu YM, Meadows GG.
    Clin Exp Metastasis; 1999 Oct; 17(10):841-8. PubMed ID: 11089882
    [Abstract] [Full Text] [Related]

  • 5. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH.
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
    Schatz F, Aigner S, Papp C, Toth-Pal E, Hausknecht V, Lockwood CJ.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
    [Abstract] [Full Text] [Related]

  • 7. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.
    Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H.
    Blood; 1991 Jul 15; 78(2):401-9. PubMed ID: 1712649
    [Abstract] [Full Text] [Related]

  • 8. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD.
    J Anat; 1999 Feb 15; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [Abstract] [Full Text] [Related]

  • 9. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
    Park KW, Choi SH, Song XX, Funahashi H, Niwa K.
    Biol Reprod; 1999 Jul 15; 61(1):298-304. PubMed ID: 10377062
    [Abstract] [Full Text] [Related]

  • 10. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R, Rifkin DB.
    Int J Cancer; 1990 Jul 15; 46(1):56-60. PubMed ID: 2142142
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S, Allan EH, Yee JA, Gelehrter TD, Martin TJ.
    J Cell Physiol; 1992 Aug 15; 152(2):346-55. PubMed ID: 1322417
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct 15; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 13. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.
    Pelayo BA, Fu YM, Meadows GG.
    Int J Oncol; 2001 Apr 15; 18(4):877-83. PubMed ID: 11251188
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 15; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 15. The role of the plasminogen system in bone resorption in vitro.
    Daci E, Udagawa N, Martin TJ, Bouillon R, Carmeliet G.
    J Bone Miner Res; 1999 Jun 15; 14(6):946-52. PubMed ID: 10352103
    [Abstract] [Full Text] [Related]

  • 16. Spitz naevi may express components of the plasminogen activation system.
    Ferrier CM, Van Geloof WL, Straatman H, Van De Molengraft FJ, Van Muijen GN, Ruiter DJ.
    J Pathol; 2002 Sep 15; 198(1):92-9. PubMed ID: 12210068
    [Abstract] [Full Text] [Related]

  • 17. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1995 Apr 15; 80(4):1100-5. PubMed ID: 7714076
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 15; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 19. Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells.
    Park SS, Li L, Korn TS, Mitra MM, Niederkorn JY.
    Curr Eye Res; 1996 Jul 15; 15(7):755-63. PubMed ID: 8670784
    [Abstract] [Full Text] [Related]

  • 20. Effect of retinoic acid on plasminogen activator expression in human melanoma cells.
    Alexander CL, Edward M, MacKie RM.
    Melanoma Res; 1999 Aug 15; 9(4):360-7. PubMed ID: 10504054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.